ProVascTec

Ireland
Cork, Munster, Ireland, T12 CY82

Company profile

ProVascTec company profile

ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee. The paracrine process of stem cells is used by ProVascTec, a preclinical stage cell treatment firm, to stimulate the development of a novel circulatory system and form a natural bypass around arterial occlusions in the peripheral vascular system, particularly below the knee.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2021-01-01, Year

Headquarters

Postal code
T12 CY82
Country code
IE
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Grant / $2.9M / 2025-09-25
Investors
2
Lead investors
2
Articles
3

Founders and investors

Lead investors

Disruptive Technologies Innovation FundEurostars

Investors

Disruptive Technologies Innovation FundEurostars